Myriad Genetics Inc. | Key People and Executives
Mark C. Capone
President, Chief Executive Officer & Director
John Tannahill Henderson
Chairman
Walter A. Gilbert
Vice Chairman
Lawrence C. Best
Independent Director
S. Louise Phanstiel
Independent Director
Heinrich Dreismann
Independent Director
Dennis H. Langer
Independent Director
Mark C. Capone
President, Chief Executive Officer & Director
Gary A. King
Executive Vice President-International Operations
R. Bryan Riggsbee
CFO, Treasurer, Principal Accounting Officer & EVP
Rishi Kacker
Chief Technology Officer
Johnathan M. Lancaster
Chief Medical Officer
Robert Gardner Harrison
Chief Information Officer
Jerry S. Lanchbury
Chief Scientific Officer
Eric A. Evans
Chief Scientific Officer-Myriad Women Health
Bryan M. DeChairo
Executive Vice President-Clinical Development
Richard S. Swartz
Executive Vice President
Nicole Lambert
General Manager-Urology Business Unit
Vicki Fish
General Manager-Dermatology
Ronald S. Rogers
Executive Vice President-Corporate Communications
Scott Gleason
Investor Relations Contact
Jayne B. Hart
Executive Vice President-Human Resources
Richard M. Marsh
Secretary, Executive VP & General Counsel
John Tannahill Henderson
Chairman
Walter A. Gilbert
Vice Chairman
Lawrence C. Best
Independent Director
S. Louise Phanstiel
Independent Director
Heinrich Dreismann
Independent Director
Dennis H. Langer
Independent Director
| Address |
320 Wakara Way
Salt Lake City Utah 84108
United States
|
|
Employees
|
- |
| Website |
http://www.myriad.com |
| Updated |
07/08/2019 |
| Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic test. It operates through Diagnostics and Other segments. The Diagnostics segment engages in the provision of testing and collaborative development of testing that is designed to asses a risk of developing a disease later in life of an individual. |
